ESR1 and ovarian cancer: In contrast, in ovarian cancer, estrogen alpha receptor inhibitor MPP has been observed to promote the expression of apoptotic proteins, including caspase-3 and Bax, and to enhance the activity of the cancer suppressor gene p53 [226].